Patent · US Expired

Dosing regimens for lasofoxifene

US6436977B1 · kind B1 · utility

12Cited by
3References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 6, 2000
Grant dateAug 20, 2002
Priority date
Expiry dateSep 6, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Based on lasofoxifene's half-life and potency, the drug may be dosed once per week and achieve a similar effect as if given daily.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.